About ViaLase
ViaLase is a company based in Newport Beach (United States) founded in 2018.. ViaLase has raised $45.18 million across 2 funding rounds from investors including Falcon-Vision, Venture Investors and Arboretum Ventures. ViaLase offers products and services including ViaLase Laser System and FLigHT Procedure. ViaLase operates in a competitive market with competitors including BELKIN Vision, ELIOS Vision, Radiance Therapeutics and EyeLight, among others.
- Headquarter Newport Beach, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vialase, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$45.18 M (USD)
in 2 rounds
-
Latest Funding Round
$45.18 M (USD), Series C
Mar 25, 2024
-
Investors
Falcon-Vision
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ViaLase
ViaLase offers a comprehensive portfolio of products and services, including ViaLase Laser System and FLigHT Procedure. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Noninvasive laser for creating apertures in trabecular meshwork to treat glaucoma.
Noninvasive glaucoma intervention without surgery or incisions.
Unlock access to complete
Funding Insights of ViaLase
ViaLase has successfully raised a total of $45.18M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $45.18 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $45.2M
-
First Round
First Round
(05 Jan 2024)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Series C - ViaLase | Valuation | Venture Investors , Arboretum Ventures |
|
| Jan, 2024 | Amount | Debt – Conventional - ViaLase | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ViaLase
ViaLase has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Falcon-Vision, Venture Investors and Arboretum Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors focused seed & early stage VC firm investing in the US, Europe & Asia
|
Founded Year | Domain | Location | |
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Founded Year | Domain | Location | |
|
Industrial machinery is manufactured and distributed by Falcon-Vision since 1996.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ViaLase
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ViaLase
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vialase Comparisons
Competitors of ViaLase
ViaLase operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BELKIN Vision, ELIOS Vision, Radiance Therapeutics and EyeLight, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Laser device for glaucoma treatment developed by BELKIN Vision.
|
|
| domain | founded_year | HQ Location |
Excimer laser technology is applied to develop glaucoma therapy devices.
|
|
| domain | founded_year | HQ Location |
Beta ophthalmic applicator for glaucoma surgery is developed.
|
|
| domain | founded_year | HQ Location |
Develops patented treatment methods for glaucoma.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vialase
Frequently Asked Questions about ViaLase
When was ViaLase founded?
ViaLase was founded in 2018 and raised its 1st funding round 6 years after it was founded.
Where is ViaLase located?
ViaLase is headquartered in Newport Beach, United States. It is registered at Newport Beach, California, United States.
Is ViaLase a funded company?
ViaLase is a funded company, having raised a total of $45.18M across 2 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $3.5M, raised on Jan 05, 2024.
What does ViaLase do?
The company was founded in 2018 and is headquartered in Newport Beach, United States. Operations center on the medical device sector, specifically ophthalmology, where image-guided femtosecond laser systems are developed for glaucoma procedures. These devices incorporate imaging technology to assist surgical interventions. Focus remains on advancing treatments for glaucoma patients through precise, non-invasive methods in a clinical setting.
Who are the top competitors of ViaLase?
ViaLase's top competitors include ELIOS Vision, BELKIN Vision and Radiance Therapeutics.
What products or services does ViaLase offer?
ViaLase offers ViaLase Laser System and FLigHT Procedure.
Who are ViaLase's investors?
ViaLase has 3 investors. Key investors include Falcon-Vision, Venture Investors, and Arboretum Ventures.